AbbVie and Gedeon Richter Announce New Collaboration for the Discovery and Development of Novel Targets for Neuropsychiatric Conditions
AbbVie (NYSE: ABBV) and Gedeon Richter Plc. ('Richter') today announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric ...
Le Lézard1h
Biologics Market Size To Reach $1,793.9 Billion By 2031 | CAGR 18.2%: The Insight Partners
According to a new comprehensive report from The Insight Partners, the global biologics market is expected to reach U.S.$ ...
Piramal Pharma Ltd: Piramal Pharma Limited Announces Results for Q2 and H1 FY25
Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness company, today announced its standalone and ...
gulftoday3h
CRISP Program, a new step by AbbVie to foster scientific expertise in the Middle East and Africa region in the field of research and development
AbbVie, a global, research-driven biopharmaceutical company, organized a visit to its R&D facilities—the AbbVie Cambridge ...
Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer
We are delighted to welcome Dr. Barbato to Incannex as our Chief Medical Officer. With an established track record in directing drug development through late-stage clinical trials and multiple product ...
Spokane woman gets back her 'normal life' from newly approved Parkinson's disease treatment
After being diagnosed with Parkinson's disease at 50, Janice Hall felt her tremors get worse. Three years after being diagnosed she could "feel a kind of fluttering" that her medication could not stop ...
Officials tour Mountainview Elementary in preparation for new STEM lab
WACO, Texas (KWTX) - Officials toured the Mountainview campus Wednesday morning to evaluate the space where a STEM lab will ...
Piramal Pharma Limited Announces Results for Q2 and H1 FY25
Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness company, today announced ...